Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-03-29
Buyer: Oslo Universitetssykehus HF — Strategi og anskaffelsesavdelingen MTV
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33100000
Estimated value: 5000000 NOK
Award criteria: The most economic tender

Technical requirements: The section for congenital metabolic illness c/o the department for medical biochemistry at Oslo universitetssykehus [Oslo University Hospital], Rikshospitalet [the National Hospital], will procure high capacity LC-MS/MS equipment to be used for quantitative and qualitative analysis of endogene drugs in biological sample material.
The section for congenital metabolic illness c/o the department for medical biochemistry at Oslo universitetssykehus [Oslo University Hospital], Rikshospitalet [the National Hospital], will procure high capacity LC-MS/MS equipment to be used for quantitative and qualitative analysis of endogene drugs in biological sample material. This equipment must be able to be configured on site for at least 6 separation columns/analysis columns, and have valves that allow software controlled column selection and must have the possibility for at least 6- 8 mobile phase solutions. The equipment will be used for laboratory diagnostics of patients and monitoring of treatment, and it must therefore be CE-IVD certified and be able to be used to achieve analyses with extremely good operational stability, selectivity, sensitivity, precision and accuracy. The equipment will i.a. be used for class specific analysis of acylcarnitines and must therefore be suited to precursor ion scans, and have ion taps to be able to perform MS3 for secure identification of new diagnostic markers. Software must have functionality for quantifying of analytes that do not have their own calibration curve, in that an analyte can be quantified using another analyte's calibration curve (use of so-called surrogate ion). There should be a short cycle time per sample on the instrument, and several different methods, so that fast switching (flexibility) between analysis methods is pre-supposed. The system must, in principle, be operable every day year round (Monday-Sunday). It must have relative sensitive mass spectrometric detection in order to enable simple sample preparation and injection of relatively small biological material. All additional components that are necessary for the analysis equipment to be operative must be included in the procurement. Examples of metabolites that will be measured with the analysis instrument are methylmalonic acid, acylcarnitines, oxalic acid, as well as purines and pyrimidines.
Tenderers must have ready established and documented internal procedures for CE-IVD that deal with documentation and reporting for all types of service visits, such as maintenance, repairs or breakdowns.
High capacity LC-MS/MS equipment will be used for quantitative and qualitative analysis of endogene drugs in biological sample material. This equipment must be able to be configured on site for at least 6 separation columns/analysis columns, and have valves that allow software controlled column selection and must have the possibility for at least 6- 8 mobile phase solutions. The equipment will be used for laboratory diagnostics of patients and monitoring of treatment, and it must therefore be CE-IVD certified and be able to be used to achieve analyses with extremely good operational stability, selectivity, sensitivity, precision and accuracy. The equipment will i.a. be used for class specific analysis of acylcarnitines and must therefore be suited to precursor ion scans, and have ion taps to be able to perform MS3 for secure identification of new diagnostic markers. Software must have functionality for quantifying of analytes that do not have their own calibration curve, in that an analyte can be quantified using another analyte's calibration curve (use of so-called surrogate ion). There should be a short cycle time per sample on the instrument, and several different methods, so that fast switching (flexibility) between analysis methods is pre-supposed. The system must, in principle, be operable every day year round (Monday-Sunday). It must have relative sensitive mass spectrometric detection in order to enable simple sample preparation and injection of relatively small biological material. All additional components that are necessary for the analysis equipment to be operative must be included in the procurement. Examples of metabolites that will be measured with the analysis instrument are methylmalonic acid, acylcarnitines, oxalic acid, as well as purines and pyrimidines. Tenderers must have ready established and documented internal procedures for CE-IVD that deal with documentation and reporting for all types of service visits, such as maintenance, repairs or breakdowns. Based on the fact that SCiex is the only supplier that, due to technical reasons, can deliver in accordance with the requirements. The intention notice is pursuant to the public procurement regulations § 21-5. The terms in FOA § 13-4 (2) and 13-1 (5) are deemed to be fulfilled as well as the value of the full service contract for the instrument's lifetime.


Winner: AB SCiex AB
Award value: 5000000